Somatostatin Radioligand Therapy of Breast Cancer: A Target of Opportunity.
作者信息
Lin Frank, Choyke Peter L
机构信息
From the Molecular Imaging Branch, National Cancer Institute, 10 Center Dr, Bldg 10, Rm B3B69F, Bethesda, MD 20892.
出版信息
Radiology. 2024 Jul;312(1):e241298. doi: 10.1148/radiol.241298.
Abstract
摘要
相似文献
1
Somatostatin Radioligand Therapy of Breast Cancer: A Target of Opportunity.乳腺癌的生长抑素放射性配体疗法：一个适时的靶点
Radiology. 2024 Jul;312(1):e241298. doi: 10.1148/radiol.241298.
2
Somatostatin receptors and breast cancer.生长抑素受体与乳腺癌
J Endocrinol Invest. 2003;26(8 Suppl):125-30.
3
Evaluation of (111)In labeled somatostatin analogs for targeted therapy of somatostatin receptor positive tumors.用于生长抑素受体阳性肿瘤靶向治疗的（111）铟标记生长抑素类似物的评估
Cancer Biother Radiopharm. 2003 Apr;18(2):249-52. doi: 10.1089/108497803765036427.
4
Somatostatin receptors imaging and therapy in a patient affected by esthesioneuroblastoma with meningeal metastases. A classic example of theranostic approach.生长抑素受体显像及治疗嗅神经母细胞瘤伴脑膜转移患者。治疗诊断方法的一个经典案例。
J Neurooncol. 2016 May;127(3):617-9. doi: 10.1007/s11060-016-2067-3. Epub 2016 Feb 2.
5
Radioguided surgery and systemic radionuclide therapy of neuroendocrine tumours.放射性导向手术和神经内分泌肿瘤的系统放射性核素治疗。
In Vivo. 2010 Jan-Feb;24(1):97-100.
6
Tumor imaging and therapy using radiolabeled somatostatin analogues.使用放射性标记的生长抑素类似物进行肿瘤成像和治疗。
Acc Chem Res. 2009 Jul 21;42(7):873-80. doi: 10.1021/ar800188e.
7
Radiolabelled somatostatin analog therapy in prostate cancer: current status and future directions.放射性标记生长抑素类似物在前列腺癌治疗中的现状与未来方向
Cancer Lett. 2006 Jul 28;239(1):21-6. doi: 10.1016/j.canlet.2005.07.020. Epub 2005 Aug 29.
8
The role of somatostatin analogs in the management of immunoproliferative disease.生长抑素类似物在免疫增殖性疾病管理中的作用。
J Endocrinol Invest. 2003;26(8 Suppl):103-8.
9
Somatostatin, its receptors and analogs, in lung cancer.生长抑素及其受体和类似物与肺癌
Chemotherapy. 2001;47 Suppl 2:78-108. doi: 10.1159/000049163.
10
Radiometal-labeled somatostatin analogs for applications in cancer imaging and therapy.用于癌症成像和治疗的放射性金属标记生长抑素类似物。
Methods Mol Biol. 2007;386:227-40. doi: 10.1007/978-1-59745-430-8_8.
本文引用的文献
1
Dotatate PET/CT and Ac-Dotatate Therapy for Somatostatin Receptor-expressing Metastatic Breast Cancer.基于生长抑素受体表达的转移性乳腺癌的奥曲肽 PET/CT 与 Ac-Dotatate 治疗
Radiology. 2024 Jul;312(1):e233408. doi: 10.1148/radiol.233408.
2
The Role of Theragnostics in Breast Cancer: A Systematic Review of the Last 12 Years. theragnostics 在乳腺癌中的作用：对过去 12 年的系统评价。
Curr Med Imaging. 2023;19(8):817-831. doi: 10.2174/1573405619666230216114748.
3
Salivary Gland Toxicity of PSMA-Targeted Radioligand Therapy with Lu-PSMA and Combined Ac- and Lu-Labeled PSMA Ligands (TANDEM-PRLT) in Advanced Prostate Cancer: A Single-Center Systematic Investigation.镥-PSMA及联合锕和镥标记的PSMA配体（TANDEM-PRLT）靶向放射性配体治疗晚期前列腺癌时的唾液腺毒性：单中心系统研究
Diagnostics (Basel). 2022 Aug 10;12(8):1926. doi: 10.3390/diagnostics12081926.
4
Diagnostic value of Ga-DOTATATE PET-CT imaging for staging of ER /PR HER2- breast cancer patients with metastatic disease: Comparison with conventional imaging with bone scan, diagnostic CT and F-FDG PET-CT in a prospective pilot trial.Ga-DOTATATE PET-CT 成像在 ER/PR HER2-转移性乳腺癌患者分期中的诊断价值：与骨扫描、诊断 CT 和 F-FDG PET-CT 常规成像的前瞻性先导试验比较。
J Med Imaging Radiat Oncol. 2022 Sep;66(6):731-737. doi: 10.1111/1754-9485.13342. Epub 2021 Oct 21.
5
Systemic Radiopharmaceutical Therapy of Pheochromocytoma and Paraganglioma.系统放射性药物治疗嗜铬细胞瘤和副神经节瘤。
J Nucl Med. 2021 Sep 1;62(9):1192-1199. doi: 10.2967/jnumed.120.259697.
6
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.镥 177-PSMA-617 治疗转移性去势抵抗性前列腺癌。
N Engl J Med. 2021 Sep 16;385(12):1091-1103. doi: 10.1056/NEJMoa2107322. Epub 2021 Jun 23.
7
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.个体化与标准剂量测定法在局部进展期肝细胞癌患者选择性内放射治疗中的应用（DOSISPHERE-01）：一项随机、多中心、开放标签的 2 期试验。
Lancet Gastroenterol Hepatol. 2021 Jan;6(1):17-29. doi: 10.1016/S2468-1253(20)30290-9. Epub 2020 Nov 7.
8
Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States.美国转移性乳腺癌女性患者数量的估计。
Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):809-815. doi: 10.1158/1055-9965.EPI-16-0889. Epub 2017 May 18.
9
Phase 3 Trial of Lu-Dotatate for Midgut Neuroendocrine Tumors.镥[177Lu]奥曲肽治疗中肠神经内分泌肿瘤的3期试验
N Engl J Med. 2017 Jan 12;376(2):125-135. doi: 10.1056/NEJMoa1607427.
10
Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy.用于肽受体闪烁显像和放射性核素治疗的放射性标记生长抑素类似物
Ann Oncol. 1999;10 Suppl 2:S23-9. doi: 10.1093/annonc/10.suppl_2.s23.
Zotero 插件